In Brief: BLA update
Executive Summary
BLA update: Report on biologics licensing application for blood products will be heard at Dec. 13 FDA Blood Products Advisory Committee meeting. The committee also will review Abbott's HTLV-1/HTLV-2 in vitro diagnostic test kit for screening blood donors. The meeting will be held at the Holiday Inn in Bethesda, Md. at 8 a.m...